Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 13, 2023
Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures, and including ACF Investors, Ascension Ventures, o2h ...
read more
Monday, September 14, 2020
Kraton is seeking regulatory approval for BIAXAM, a novel sulfonated polymer technology with long-lasting self-disinfecting properties.
read more
KPMG's Clinical Intelligence platform is providing clinicians with pharmacogenomics data from Coriell Life Sciences, supported by Thermo Fisher Scientific's genetic analysis platform and content.
read more
As the holding company of the Medipak Systems Business Area, Körber Medipak Systems GmbH is aiming to use the acquisition to extend its expertise in the cutting-edge market for software solutions in the field of production control and monitoring. ...
read more
Konica Minolta and Ambry Genetics announced the signing of a definitive agreement for a subsidiary of Konica Minolta to acquire Ambry.
read more
Kodiak Sciences Inc. and Lonza announced the opening of a new, custom-built, bioconjugation facility within Lonza’s Ibex® Dedicate manufacturing complex in Visp (CH).
read more
Monday, December 02, 2019
Kodiak Sciences announced the Company has entered into a funding agreement to sell a capped royalty right on global net sales of KSI-301 to Baker Bros. Advisors for $225 million.
read more
Tuesday, February 09, 2016
Lonza and Kodiak Sciences Inc, have announced agreements for the clinical supply of Kodiak's therapeutic candidates. Under the agreement, Lonza will manufacture material at multiple sites, including Slough (UK), Visp (CH) and Nansha (CN).
read more
Klöckner Pentaplast is breaking ground on a large expansion at its Klöckner Barrier Film facility in central Virginia in the United States.
read more
Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division announces a 5 million Euro investment in their Cotia, Brazil facility.
read more
Klöckner Pentaplast’s Pharma & Medical Device Division announced it will add to its global production capacity in North America.
read more
Wednesday, April 01, 2020
Kleo has entered into a research collaboration with GCLC to rapidly advance testing of both advanced technology platforms in combination as a potential therapy for COVID-19 patients.
read more
Thursday, August 03, 2017
PharMerica announced that it has entered into a definitive merger agreement pursuant to which a newly formed company controlled by KKR, with Walgreens Boots Alliance as a minority investor, will acquire PharMerica.
read more
Friday, February 23, 2018
Kite and Sangamo announced the companies have entered into a worldwide collaboration using Sangamo’s ZFN technology platform for the development of next-generation ex vivo cell therapies in oncology.
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies...
read more